John O'brien
About John O'brien
John O'Brien is a scientist currently employed at Entrada Therapeutics in Boston, Massachusetts, where he has worked since 2021. He has held various scientific roles in the biotechnology and pharmaceutical industries, including positions at GnuBIO, Sanofi Genzyme, Inari, and Bristol-Myers Squibb.
Work at Entrada Therapeutics
John O'Brien has been employed as a Scientist at Entrada Therapeutics since 2021. His role is based in Boston, Massachusetts, where he has contributed to the company's research and development efforts for three years. Entrada Therapeutics focuses on advancing therapies for patients with serious diseases, and O'Brien's expertise plays a significant role in their scientific initiatives.
Previous Experience in Biotechnology
Before joining Entrada Therapeutics, John O'Brien held several positions in the biotechnology sector. He worked as a Research Scientist II at Sanofi Genzyme from 2017 to 2018. Prior to that, he served as a Research Scientist at Inari from 2018 to 2021 and as an Associate Research Scientist at Bristol-Myers Squibb from 2015 to 2017. His experience spans various roles, contributing to advancements in biological research.
Early Career in Biology and Audio Engineering
John O'Brien's career began in audio engineering, where he founded Ad Astra Entertainment and worked as an Audio Engineer from 2002 to 2012. He later transitioned to the biotechnology field, starting as a Biology Associate at GnuBIO, Inc. from 2013 to 2014. This diverse background demonstrates his adaptability and broad skill set across different industries.
Educational Background in Biology and Psychology
John O'Brien earned a Bachelor of Science degree in Biology with a minor in Psychology from the University of Rhode Island. His studies, completed between 2006 and 2011, provided him with a solid foundation in biological sciences and an understanding of psychological principles, which are applicable in his scientific career.